TROL Act Reintroduced in House

Strong patents are the lifeblood of the biotech industry. They are critical in ensuring a steady stream of capital to companies developing innovative medicines, alternative energy sources, and insect and drought resistant crops – capital that would otherwise flow into less risky investments if patents were not strong. The majority of biotech companies have no products on the market, and thus their research and development activities are funded through massive amounts of investment, largely